20 May 2013
Keywords: Sanofi, Regeneron Pharma, Zaltrap, Colorectal cancer, USA, FDA
Article | 06 August 2012
The US Food and Drug Administration on Friday approved French drug major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals& ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 August 2012
17 May 2013
© 2013 thepharmaletter.com